Skip to main content
Premium Trial:

Request an Annual Quote

Swift Biosciences, Genomenon to Co-Market NGS Panel Design Service

NEW YORK (GenomeWeb) – Swift Biosciences and Genomenon said today that they have entered a new partnership in which they will co-market a service for the design and creation of targeted gene sequencing panels.

In the companies' new combined service, Genomenon will use its automated machine learning approach and Mastermind Genomic Search Engine to identify biomarker targets associated with diseases, producing a list of candidate biomarkers. It will then curate these biomarkers based on the strength and quality of the scientific evidence found in the literature, delivering a final prioritized set.

Swift's role is then to build and validate Accel-Amplicon Custom NGS Panels for the targets in question. The company's technology combines a two-hour, single-tube workflow with highly multiplexed, targeted PCR libraries that are compatible with both Illumina and Ion Torrent sequencing platforms, as well as with most sample types, including limited or degraded samples such as FFPE and cell-free DNA.

Financial and other details of the collaboration were not disclosed.

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.